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telephone counseling can significantly improve blood pressure control. Our data 
show also that interventions run by allied health professionals (i.e. other than 
the prescriber/doctor), improve adherence to medicines and promote 
hypertension-related health behaviors.  
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OBJECTIVES: To describe initially-prescribed drug treatments for hypertension in 
newly-diagnosed recipients in a Medicaid population and to determine factors 
affecting 6- and 12-month persistence rates. METHODS: This retrospective study 
included continuously-enrolled Louisiana Medicaid recipients aged 18-64 who 
were newly-diagnosed with hypertension between January 2006 and December 
2008. Dually-eligible recipients were excluded. Recipients were followed for one 
year after their index date. Initial drug therapy was described, and persistence 
rates were calculated 6- and 12-months post-index, for recipients who received 
diuretics, beta-blockers (BBs), angiotensin-II receptor blockers (ARBs), 
angiotensin converting enzyme inhibitors (ACEIs), and calcium channel blockers 
(CCBs). A 30-day grace period was allowed for refill gaps. Race, gender, age, and 
co-morbidity were used as predictor variables in logistic regression analyses of 
persistence for each drug class. RESULTS: A total of 4946 recipients were eligible 
for inclusion. Of these, 2352 received no drug therapy and 289 did not receive 
therapy in one of the analyzed drug classes, leaving a final study group of 2305 
recipients. The study group was primarily female (68%) and African-American 
(67%). The majority of recipients received diuretics, followed by ACEIs, ARBs, BBs, 
and CCBs. Persistence rates for initially-prescribed drugs ranged from 21.6% for 
diuretics to 31.6% for ACEIs at 6-months, and from 10.7% for diuretics to 17.9% 
for CCBs at 12-months. Within drug classes, persistence ranged from 24.2% for 
diuretics to 33.1% for ACEIs at 6-months and 12.4% for diuretics to 19.3% for BBs 
at 12-months. Race, gender, and age were significant factors predicting 
persistence, with African-Americans less persistent than Whites, females less 
persistent than males, and younger recipients less persistent than older 
recipients. CONCLUSIONS: Approximately half of newly-diagnosed recipients did 
not receive drug therapy, and among treated patients, persistence rates were 
poor. Race, gender, and age were factors influencing persistence of therapy in 
this study group.  
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OBJECTIVES: Recent studies have documented high rates of non-administration 
of ordered venous thromboembolism (VTE) prophylaxis doses. Intervention 
strategies that target all patients have been effective, but prohibitively resource-
intensive. We aimed to identify efficient intervention strategies based on 
patterns of non-administration of ordered VTE prophylaxis. METHODS: In this 
retrospective review of electronic medication administration records, we 
included adult hospitalized patients who were ordered pharmacologic VTE 
prophylaxis with unfractionated heparin or enoxaparin over a seven-month 
period. The primary measure was the proportion of ordered doses of VTE 
prophylaxis not administered, assessed at the patient, floor, and floor type 
levels. Differences in non-administration rates between groups were assessed 
using generalized estimating equations. RESULTS: A total of 103,160 ordered VTE 
prophylaxis doses during 10,516 patient visits on twenty-nine patient floors were 
analyzed. Overall, 11.9% of ordered doses were not administered. Approximately 
19% of patients missed at least one quarter and 8% of patients missed over one 
half of ordered doses. There was marked heterogeneity in non-administration 
rate at the floor level (range: 5-27%). Patients on medicine floors missed a 
significantly larger proportion (18%) of ordered doses compared to patients on 
other floor types (8%, Odds Ratio: 2.4, p<0.0001). However, more than half of 
patients received at least 86% of their ordered doses, even on the lowest 
performing floor. The 20% of patients who missed at least two ordered doses 
accounted for 80% of all missed doses. CONCLUSIONS: A substantial proportion 
of ordered doses of VTE prophylaxis were not administered. The heterogeneity in 
non-administration rate between patients, floors, and floor types can be used to 
target interventions. The small proportion of patients that missed multiple 
ordered doses accounted for a large majority of non-administered doses. This 
recognition of the Pareto principle provides opportunity to efficiently target a 
relatively small group of patients for intervention.  
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OBJECTIVES: In 2007 the Work Group of Cardarelli Hospital (Naples, Italy) 
developed a therapeutic education program to reduce blood pressure (BP) in 
patients with hypertension through a better adherence to pharmacological and 
non pharmacological treatment. The program was funded by a grant from Italian 
Agency of Drugs (AIFA). The activity involved General Practitioners (GPs) from 
Campania region METHODS: The study was an experimental controlled trial 
with the enrolment of 2329 (1139 Intervention and 1190 Controls). Group 
Intervention (I) patients participated to 3 educational sessions (two focus group 
and one role play) respectively 2, 4 and 9 months after the recruitment. Group 
Control (C) patients received usual care. Blood pressure values were registered at 
the baseline and after 12 months. Focus groups are qualitative interviews with a 
small number of people brought together to discuss a host of topics under the 
guide of a "moderator". Role play is a simulation that reflects a situation found in 
the real world.The aim of role play is to learn how to perform the instructions 
and how to best handle a situation by practicing and interacting with people 
who share the same condition. Univariate General Linear models (GLM) were 
used to compare mean variation in systolic and diastolic blood pressure 
(SBP;DBP) between groups (Intervention and control) after adjusting for the 
covariates measured at baseline. RESULTS: Adjusted mean reduction of SBP was-
1.6mmHG 95% C.I [-6.3mmHG ; +3.1mmHG] in the intervention group and 
+0.8mmHG; 95% C.I [-3.9mmHG ; +5.4mmHG] in the control group. The different 
behavior of the two groups led to a significant treatment effect (Intervention vs 
Control) equal to-2.4mmHG,95% C.I [-3.4 mmHG ; -1.3mmHG]. CONCLUSIONS: 
Our findings show that a patient-oriented approach is a powerful tool for 
reaching better blood pressure control and underlying the essential role of 
patients involvement in the management of their care.  
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OBJECTIVES: A recent study at our institution indicated that 12.8% of all 
prescribed doses of venous thromboembolism (VTE) prophylaxis are not 
administered, with some nursing units approaching 30%. Our goal was to assess 
nursing beliefs and practices related to non-administration of ordered VTE 
prophylaxis doses. METHODS: We conducted a mixed-methods study, including 
qualitative observation and quantitative survey assessment. The study was 
conducted on twelve inpatient nursing units with disparate non-administration 
rates of ordered VTE prophylaxis doses of either unfractionated heparin or 
enoxaparin. Qualitative aspects of the nurse-patient encounter were directly 
observed by the lead investigator at the scheduled administration time of VTE 
prophylaxis until thematic saturation was achieved. A survey was distributed to 
all nurses on the included floors to identify beliefs and practices regarding non-
administration of ordered VTE prophylaxis doses. RESULTS: Low-performing 
units had an average pharmacologic VTE prophylaxis non-administration rate of 
18%, compared to the high-performing units which averaged a non-
administration rate of 10%. During observations, some nurses presented 
pharmacologic VTE prophylaxis to their patients as an optional therapy and 
entered into negotiations with their patients whereby patients could promise to 
walk to avoid a dose. Nurses on low-performing units were more likely to 
respond that VTE prophylaxis was prescribed for patients who do not require it 
(83% vs. 62%, p<0.0001) and were also more likely to believe that they had the 
clinical decision-making skills to determine when to omit unnecessary doses of 
prescribed VTE prophylaxis (80% vs. 50%, p<0.0001). Workload was not identified 
as a reason for non-administration on either high- or low-performing units. 
CONCLUSIONS: Nurses on low-performing units more often believe they have 
the skills to determine which patients require pharmacologic VTE prophylaxis 
and are more likely to present the medication as optional to patients. Strategies 
to improve administration rates should incorporate these findings.  
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OBJECTIVES: Adherence to medications (AM) has been a major research priority 
for recent decades. Numerous factors including poor access to medicines have 
been identified to affect AM particularly in middle income countries (MIC). 
However, access to medicines seems to be addressed well in Iran as a MIC but 
little is known about the rate and the determinants of AM for Iranian patients. In 
the present study, we systematically reviewed the AM literature related to 
Iranian patients with diabetes (DM) and cardiovascular diseases (CVD). 
METHODS: We searched biomedical databases including Scopus, Web of Science, 
PubMed, CINAHL, and Google Scholar, Scientific Information Database, and 
IranMedex from inception to July 2012. Two independent researchers screened 
all abstracts. Studies were included if they reported rate of adherence to CVD or 
DM medications in Iran. We also included studies which had focused on AM 
determinants or AM improving interventions. Two teams of researchers 
reviewed full-texts of the relevant articles for quality appraisal and data 
extraction. We preferred qualitative synthesis of literature as the AM definitions 
and measurement tools were highly diverse among studies. RESULTS: Among 
1003 citation, fourteen studies were eligible for review. Adherence rate for 
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diabetic patients was 62.8-86.3% and for patients with CVD was 38.8-60.0%. 
Forgetfulness, lack of knowledge about medical condition and prescribed 
medications, and concerns about medications were consistently reported as 
barriers to AM. Patient education plus telephone or short message service follow-
ups improved AM in diabetic patients. We found no high quality trials on AM 
improving interventions for patients with CVD. CONCLUSIONS: Non-adherence 
to medications may not be assured for accessible medicines in resource-limited 
settings. We strongly suggest for multidisciplinary policies and interventions on 
patient education and reinforcement strategies to address the issue of non-
adherence to medications.  
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OBJECTIVES: Much research exists on medication adherence, however, clear 
evidence is lacking on specific methods to achieve lower rates of non-
compliance. The purpose of this study was to evaluate the differences in 
cholesterol medication adherence at primary care practices who have 
implemented a patient centered medical home (PCMH) as compared to usual 
primary care (UPC). METHODS: A retrospective cohort study analyzed medical 
and pharmacy claims from continuously enrolled Medicare Part D members at 
least 18 years old at UPMC Health Plan. We compared PCMH and USP practices 
over a one year period (2011) for medication adherence of statin drugs. 
Standardized metrics from the Medicare Health and Drug Plan Quality and 
Performance Ratings 2012 were used. Exclusion criteria were as follows: switched 
between PCMH/UPC practice in 2011; pharmacist on-site at practice; PCMH 
implemented for <6 months at practice. Members who had at least 2 fills in the 
same drug class during the period were included. RESULTS: A total of 1,227 
members in 21 PCMH practices were compared to 17,599 members in 1,283 UPC 
practices. Chi-square tests showed no difference in age, sex or disease burden 
(using Charleson Comorbidity Index) between the groups. There was a 
significant increase in the percentage of members with a medication possession 
ratio (MPR) of at least 80% for cholesterol medications (75.7% in PCMH vs.72.9% in 
UPC), p=0.03. CONCLUSIONS: This research informs investment in the PCMH 
model which may have an unreported value stream related to medication 
adherence. The increase in percentage of members with MPR>=80% in the PCMH 
group translates to increased CMS star rating of 5. The 5 Star threshold is 75.4%. 
This is of benefit to the insurer towards the contribution of the overall CMS Star 
Rating of the Medicare plan, as this metric is weighted three times more than 
most measures.  
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OBJECTIVES: In addition to warfarin, the drugs dabigatran and rivaroxaban have 
been used to prevent strokes in patients with atrial fibrillation. However, their 
impact on patients’ health-related quality of life remains unknown. This study 
aimed to use the visual analogue scale (VAS) and standard gamble (SG) to elicit 
patient-reported utilities for health states related to stroke and stroke 
prophylaxis by the three anticoagulants. METHODS: A cross-sectional survey 
was administered in 2012 to a convenience sample of 100 patients taking 
warfarin in an anticoagulation clinic. The survey questionnaire included socio-
demographics, clinical characteristics, and questions to elicit utilities for seven 
chronic and four temporary health states. Participants completed the 
questionnaire in English or Chinese, depending on their preference. Logical 
consistency and correlations between the VAS and SG were assessed. RESULTS: 
When the SG was used, the three health states with the highest mean utilities 
were “well on rivaroxaban” (0.90), “current health state” (0.86) and “well on 
warfarin” (0.86). The three health states with the lowest mean utilities were 
intracranial bleeding (ICH) (-0.09), major ischemic stroke (IS) (-0.01) and 
myocardial infarction (0.45). Logical consistency was found: 1) the mean utilities 
of “well on warfarin”, “well on dabigatran”, “well on rivaroxaban” and “current 
health state” were higher than those of other chronic health states (all p<0.001); 
2) the mean utilities of major IS and ICH were lower than those of minor IS and 
transient ischemic attack (all p<0.001); and 3) the mean utility of major 
extracranial hemorrhage (ECH) was lower than that of minor ECH (all p<0.001). 
Significant correlations were found between the two measures (all p<0.05). 
CONCLUSIONS: The elicited utilities of the anticoagulants were, in a decreasing 
order: rivaroxaban, warfarin and dabigatran. The results of this study can be 
used in future cost-utility analysis.  
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OBJECTIVES: Traditional Chinese Medicine Syndrome Angina Questionnaire 
(TCMSAQ) was a well-developed disease and syndrome combined questionnaire. 
The syndromes domains were alternated when evaluating the corresponding 
syndromes. In this research, we offered a new view for scale development and 
applications—Disease Generic Module (DGM) and Syndrome Specific Module 
(SSM). Thus, the aim was to reset the TCMSAQ, evaluate the TCMSAQ-DGM’s 
psychometrics, and apply it. METHODS: The data resources came from a cross-
sectional clinical survey of angina patients in 12 centered hospitals. All the 
participants filled in the TCMSAQ-DGM with 5 domains (without syndrome) and 
22 items. Seattle Angina Questionnaire (SAQ) and SF-12 were administered to 
assess criterion validity. The reliability was evaluated on the basis of internal 
consistency, test-retest reliability. Construction validity was tested by 
exploratory factor analysis (EFA). Discriminate validity was assessed by detecting 
differences from known groups with different Canadian Cardiovascular Society 
Classification (CCSC) levels and Body Mass Index (BMI). RESULTS: A total of 1756 
(98.21%) patients (PBS, 785; QBS, 777; age 59±10 years; 905 male, 52%) participated 
the research. TCMSAQ-DGM Cronbach’s alpha coefficient was 0.822; Test-retest 
correlation coefficient (CC) was 0.946 (P=0.00). EFA showed 7 factors matching 
the expected conceptual framework. Criterion validity demonstrated that 
TCMSAQ-DGM related with SAQ similar domains (CC, 0.108~0.771; P=0.00). The 
mean scores of the TCMSAQ-DGM in patients with CCSC ±to ‡W were 74.58, 
72.26, 67.56, 55.25 (P=0.00) and also can TCMSAQ-DGM distinguish patients in 
activity limitations and worry domains with different CCSC levels. However, the 
Body Mass Index (BMI>25 indicated overweight) manifested that overweight 
patients were more worried about the death of angina. Considering two different 
syndromes, TCMSAQ-DGM only showed PBS patients’ sleep better than QBS 
individuals’. CONCLUSIONS: The reset TCMSAQ-DGM has good psychometric 
properties, and can be applied in TCM clinical practice. Further researches of 
DGM and SSM’s relationship and applications will be discussed.  
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OBJECTIVES: To assess the reliability of the quality of life instrument used in the 
COURAGE trial. METHODS: We used data from the COURAGE study, a 
randomized trial evaluating the outcomes of optimal medical therapy (OMT) 
with or without percutaneous coronary intervention (PCI). A total of 2,287 
patients with stable Coronary disease were enrolled and followed for a median of 
4.6 years. Angina-specific health status was assessed with the Seattle Angina 
Questionnaire (SAQ) at baseline and at 1, 3, 6 and 12 months followed by annual 
evaluations. The SAQ consists of five domains: the physical limitation, angina 
stability, angina frequency, treatment satisfaction, and quality of life. Scores in 
each domain range from 0 to 100, with higher scores indicating better health 
status. Cronbach’s alpha was used to estimate the reliability of each domain in 
SAQ. RESULTS: At baseline, the correlation coefficients between the domain of 
physical limitation, angina frequency, or quality of life and the composite score 
of all five domains were 0.54, 0.63, and 0.65, respectively; but the coefficients 
between the angina stability or treatment satisfaction and the composite score 
were 0.49, and 0.27, respectively. If the domain of physical limitation, angina 
frequency, or quality of life is deleted, Cronbach’s alpha will decrease from 0.75 
to 0.69, 0.66, or 0.64, respectively; however, if the angina stability is deleted, 
Cronbach’s alpha will change from 0.75 to 0.72, and if the treatment satisfaction 
is deleted, Cronbach’s alpha will increase from 0.75 to 0.78. Similar results can be 
seen over the follow-up time. CONCLUSIONS: The angina stability and treatment 
satisfaction domains should be excluded since they had weak relationship with 
the entire SAQ instrument. Three domains of the physical limitation, angina 
frequency, and quality of life thoroughly reflected the impact of angina on a 
patient’s health status and disease related quality of life.  
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OBJECTIVES: It is well documented that antithrombotic therapies prevent 
thrombotic events (benefits) in many clinical settings, but also are associated 
with an increased risk of bleeding (risks). However, it is not entirely clear how 
the tradeoff between these health outcomes is perceived by patients and 
physicians, particularly when treating acute coronary syndrome (ACS). The 
current study aims to quantify US patient and physician preferences for health 
outcomes associated with antithrombotic therapies in ACS. METHODS: Patients 
≥18 years old who were hospitalized within the last 5 years due to a heart attack 
and have used aspirin or prescription blood thinners, and board-certified 
cardiologists participated in a web-based, best-worst scaling survey. Each best-
worst scaling question included 3 possible outcomes and participants were 
asked to select the best and worst outcomes in each question. Outcomes 
included death, and various levels of stroke, myocardial infarction, and bleeding. 
Data were analyzed using a maximum difference model employing random-
parameters logit. RESULTS: Responses from 206 patients and 273 physicians met 
face validity requirements and were analyzed. For both physicians and patients, 
non-fatal major disabling stroke was nearly equivalent to death in terms of 
relative importance, and non-fatal moderate bleeding was the least important. 
For physicians, severe myocardial infarction was equivalent to 0.92 (standard 
error, ±0.02) deaths, while non-fatal moderate stroke was equivalent to 0.64 
(±0.05) deaths. For patients, non-fatal moderate stroke was equivalent to 0.35 
(±0.04) deaths, while non-fatal major bleeding requiring transfusion was 
equivalent to 0.13 (±0.02) deaths, and non-fatal heart attack was equivalent to 
0.09 (±0.02) deaths. All remaining ACS outcomes were equivalent to fewer than 
0.03 deaths. CONCLUSIONS: US patients and physicians viewed death and 
disabling stroke as the most important and non-fatal moderate bleeding as the 
